China Pharma Holdings (CPHI) Receivables - Other (2016 - 2025)
Historic Receivables - Other for China Pharma Holdings (CPHI) over the last 16 years, with Q3 2025 value amounting to $61275.0.
- China Pharma Holdings' Receivables - Other rose 3162.42% to $61275.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $61275.0, marking a year-over-year increase of 3162.42%. This contributed to the annual value of $30286.0 for FY2024, which is 8082.48% down from last year.
- Per China Pharma Holdings' latest filing, its Receivables - Other stood at $61275.0 for Q3 2025, which was up 3162.42% from $48361.0 recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Receivables - Other ranged from a high of $1.7 million in Q3 2021 and a low of $28660.0 during Q2 2024
- Its 5-year average for Receivables - Other is $551357.2, with a median of $61275.0 in 2025.
- Per our database at Business Quant, China Pharma Holdings' Receivables - Other tumbled by 9795.53% in 2022 and then skyrocketed by 44203.64% in 2023.
- China Pharma Holdings' Receivables - Other (Quarter) stood at $1.4 million in 2021, then plummeted by 97.96% to $29139.0 in 2022, then soared by 442.04% to $157944.0 in 2023, then tumbled by 80.82% to $30286.0 in 2024, then soared by 102.32% to $61275.0 in 2025.
- Its Receivables - Other stands at $61275.0 for Q3 2025, versus $48361.0 for Q2 2025 and $39046.0 for Q1 2025.